Adaptive Biotechnologies Corp — Director's Dealing 2020

May 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-02-13

Reporting Person: GOEL DAVID E. (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-13	Stock Option (Right to Buy)	$31.71	A	8888	Acquired	2030-02-13	Common Stock (8888)	Direct

Footnotes

F1: The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date.

F2: The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.